Inhibition of opioid-degrading enzymes potentiates Δ9-tetrahydrocannabinol-induced antinociception in mice
- 1 February 1998
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 37 (2) , 215-222
- https://doi.org/10.1016/s0028-3908(98)00005-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Degradation of Dynorphin‐Related Peptides by the Puromycin‐Sensitive Aminopeptidase and Aminopeptidase MJournal of Neurochemistry, 1995
- AM630, a competitive cannabinoid receptor antagonistLife Sciences, 1995
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- The degradation of dynorphin A in brain tissue in vivo and in vitroPeptides, 1987
- The enkephalinase inhibitor thiorphan shows antinociceptive activity in miceNature, 1980
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977